Latest News for: Kenai
Edit
Ravalli Republic
08 Jul 2026
Kenai Therapeutics Announces Completion of Enrollment in Phase 1b/2a REPLACE™ Trial of RNDP-001 in Idiopathic ...
SAN DIEGO, July 7, 2026 /PRNewswire/ -- Kenai Therapeutics, ...
Edit
Kenai Therapeutics Announces Completion of Enrollment in Phase 1b/2a REPLACE™ Trial of RNDP-001 in Idiopathic Parkinson's Disease
PR Newswire 07 Jul 2026
"Completing enrollment in the REPLACE trial is an important milestone for Kenai and a meaningful step in advancing our program for patients with Parkinson's disease," said Nick Manusos, Chief Executive Officer of Kenai Therapeutics.
- 1